Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events

被引:19
|
作者
Wu, Feitong [1 ,2 ,3 ]
Juonala, Markus [4 ,5 ]
Jacobs Jr, David R. [6 ]
Daniels, Stephen R. [7 ]
Kahonen, Mika [8 ,9 ]
Woo, Jessica G. [10 ,11 ]
Sinaiko, Alan R. [12 ]
Viikari, Jorma S. A. [4 ,5 ]
Bazzano, Lydia A. [13 ]
Burns, Trudy L. [14 ]
Steinberger, Julia [15 ]
Urbina, Elaine M. [11 ,16 ]
Venn, Alison J. [1 ]
Raitakari, Olli T. [17 ,18 ,19 ,20 ,21 ]
Dwyer, Terence [1 ,22 ,23 ]
Magnussen, Costan G. [1 ,2 ,17 ,18 ,19 ]
机构
[1] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia
[2] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[3] Univ Melbourne, Fac Med Dent & Hlth Sci, Baker Dept Cardiometabol Hlth, Melbourne, Vic, Australia
[4] Univ Turku, Dept Med, Turku, Finland
[5] Turku Univ Hosp, Div Med, Turku, Finland
[6] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[7] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[8] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[9] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland
[10] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA
[11] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[12] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[13] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA
[14] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA
[15] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA
[16] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA
[17] Univ Turku, Ctr Populat Hlth Res, Turku, Finland
[18] Turku Univ Hosp, Turku, Finland
[19] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland
[20] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland
[21] Univ Turku, InFLAMES Res Flagship, Turku, Finland
[22] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England
[23] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
基金
欧洲研究理事会; 芬兰科学院; 英国医学研究理事会; 美国国家卫生研究院;
关键词
atherosclerosis; epidemiology; lipoproteins; longitudinal studies; risk assessment; risk factors; UNITED-STATES; HEART; EXERCISE; ADHERENCE; RISK; GUIDELINES; CHILDREN; OUTCOMES; UTILITY; YOUTH;
D O I
10.1161/CIRCULATIONAHA.123.064296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Although low-density lipoprotein cholesterol (LDL-C) remains the primary cholesterol target in clinical practice in children and adults, non-high-density lipoprotein cholesterol (non-HDL- C) has been suggested as a more accurate measure of atherosclerotic cardiovascular disease (ASCVD) risk. We examined the associations of childhood non-HDL-C and LDL- C levels with adult ASCVD events and determined whether non-HDL- C has better utility than LDL-C in predicting adult ASCVD events. METHODS: This prospective cohort study included 21 126 participants from the i3C Consortium (International Childhood Cardiovascular Cohorts). Proportional hazards regressions were used to estimate the risk for incident fatal and fatal/nonfatal ASCVD events associated with childhood non-HDL- C and LDL-C levels (age- and sex-specific z scores; concordant/discordant categories defined by guideline-recommended cutoffs), adjusted for sex, Black race, cohort, age at and calendar year of child measurement, body mass index, and systolic blood pressure. Predictive utility was determined by the C index. RESULTS: After an average follow-up of 35 years, 153 fatal ASCVD events occurred in 21 126 participants (mean age at childhood visits, 11.9 years), and 352 fatal/nonfatal ASCVD events occurred in a subset of 11 296 participants who could be evaluated for this outcome. Childhood non-HDL-C and LDL-C levels were each associated with higher risk of fatal and fatal/nonfatal ASCVD events (hazard ratio ranged from 1.27 [95% CI, 1.14-1.41] to 1.35 [95% CI, 1.13-1.60] per unit increase in the risk factor z score). Non-HDL-C had better discriminative utility than LDL-C (difference in C index, 0.0054 [95% CI, 0.0006-0.0102] and 0.0038 [95% CI, 0.0008-0.0068] for fatal and fatal/nonfatal events, respectively). The discordant group with elevated non-HDL-C and normal LDL-C had a higher risk of ASCVD events compared with the concordant group with normal non-HDL- C and LDL-C (fatal events: hazard ratio, 1.90 [95% CI, 0.98-3.70]; fatal/nonfatal events: hazard ratio, 1.94 [95% CI, 1.23-3.06]). CONCLUSIONS: Childhood non-HDL-C and LDL-C levels are associated with ASCVD events in midlife. Non-HDL-C is better than LDL-C in predicting adult ASCVD events, particularly among individuals who had normal LDL-C but elevated non-HDL-C. These findings suggest that both non-HDL-C and LDL-C are useful in identifying children at higher risk of ASCVD events, but non-HDL-C may provide added prognostic information when it is discordantly higher than the corresponding LDL-C and has the practical advantage of being determined without a fasting sample.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 50 条
  • [21] Non-HDL cholesterol: Into the spotlight
    Hsia, SH
    DIABETES CARE, 2003, 26 (01) : 240 - 242
  • [22] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis
    Boekholdt, S. Matthijs
    Arsenault, Benoit J.
    Mora, Samia
    Pedersen, Terje R.
    LaRosa, John C.
    Nestel, Paul J.
    Simes, R. John
    Durrington, Paul
    Hitman, Graham A.
    Welch, K. M. A.
    DeMicco, David A.
    Zwinderman, Aeilko H.
    Clearfield, Michael B.
    Downs, John R.
    Tonkin, Andrew M.
    Colhoun, Helen M.
    Gotto, Antonio M., Jr.
    Ridker, Paul M.
    Kastelein, John J. P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12): : 1302 - 1309
  • [23] Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population
    Nantsupawat, Nopakoon
    Booncharoen, Apaputch
    Wisetborisut, Anawat
    Jiraporncharoen, Wichuda
    Pinyopornpanish, Kanokporn
    Chutarattanakul, Lalita
    Angkurawaranon, Chaisiri
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (1)
  • [24] Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
    Du, Tingting
    Sun, Xingxing
    Yu, Xuefeng
    LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [25] Pediatric reference intervals for calculated LDL cholesterol, non-HDL cholesterol, and remnant cholesterol in the healthy CALIPER cohort
    Higgins, V.
    Asgari, S.
    Chan, M. K.
    Adeli, K.
    CLINICA CHIMICA ACTA, 2018, 486 : 129 - 134
  • [26] A comparison of non-HDL and LDL cholesterol goal attainment in the CHILLAS trial
    Yu, Bi-lian
    Zhao, Shui-ping
    Peng, Dao-quan
    Huo, Yong
    Hu, Lu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 4340 - 4342
  • [27] Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population
    Nopakoon Nantsupawat
    Apaputch Booncharoen
    Anawat Wisetborisut
    Wichuda Jiraporncharoen
    Kanokporn Pinyopornpanish
    Lalita Chutarattanakul
    Chaisiri Angkurawaranon
    Lipids in Health and Disease, 18
  • [28] Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
    Tingting Du
    Xingxing Sun
    Xuefeng Yu
    Lipids in Health and Disease, 16
  • [29] Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study
    Yun, Shin Young
    Rim, John Hoon
    Kang, Hyein
    Lee, Sang-Guk
    Lim, Jong-Baeck
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (03) : 237 - 243
  • [30] Non-HDL Cholesterol and Long-Term cardiovascular risk
    Wolfram, Guenther
    AKTUELLE ERNAHRUNGSMEDIZIN, 2020, 45 (03): : 159 - 160